Wikidata

(Q40099871)

English

The anticancer activity of the transcription inhibitor terameprocol (meso-tetra-O-methyl nordihydroguaiaretic acid) formulated for systemic administration

scientific article published on September 2007

In more languages

Statements

title
The anticancer activity of the transcription inhibitor terameprocol (meso-tetra-O-methyl nordihydroguaiaretic acid) formulated for systemic administration (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17667599
retrieved
17 September 2017
author name string
Rocio A Lopez
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
17667599
retrieved
17 September 2017
Amanda B Goodman
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
17667599
retrieved
17 September 2017
Melissa Rhodes
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
17667599
retrieved
17 September 2017
Jessica A L Blomberg
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
17667599
retrieved
17 September 2017
Jonathan Heller
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
17667599
retrieved
17 September 2017
publication date
1 September 2007
1 reference
stated in
Europe PubMed Central
PubMed ID
17667599
retrieved
17 September 2017
page(s)
933-939
1 reference
stated in
Europe PubMed Central
PubMed ID
17667599
retrieved
17 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40099871&oldid=1885284962"